Enanta Pharmaceuticals
ENTA
#7604
Rank
NZ$0.70 B
Marketcap
NZ$24.32
Share price
3.31%
Change (1 day)
143.29%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2025 (TTM): NZ-$6.63

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.49. In 2024 the company made an earnings per share (EPS) of NZ-$8.39.

EPS history for Enanta Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.63-21%
2024NZ-$8.39
2021NZ-$8.4472.92%
2020NZ-$4.88-267.44%
2019NZ$2.92-61.35%
2018NZ$7.54147.22%
2017NZ$3.05-460%
2016NZ-$0.85-114.88%
2015NZ$5.69-23.81%
2014NZ$7.47-244.12%
2013NZ-$5.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.88-390.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.20-287.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$4.05-162.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$26.22-503.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.39-290.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.86-190.34%๐Ÿ‡บ๐Ÿ‡ธ USA